SEC Form D private-offering filing

Allyx Therapeutics, Inc.

Name: Allyx Therapeutics, Inc. - new SEC Form D private-offering filing, New Haven, CT
Published: 2026-03-03

A new SEC Form D private-offering notice from New Haven, CT, a $4,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Allyx Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical-stage biotech developing oral therapies, led by ALX-001, to protect synapses and treat neurodegenerative diseases including Alzheimer's and Parkinson's.

Filed 2026-03-03Filed to raise $4,000,000First money in 2026-02-23Raised so far $3,324,918HQ (as filed) New Haven, CTSector Biotech ✓Stage (inferred) SeedCall status Call-ready

Source linked the Form D on EDGAR↗Website verified allyxthera.com↗Named in the filing 7 executives & directors

Open this row on the live feed →More new filings in Connecticut →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.